Regulon

Regulon: R-859

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
92.036514Pr-165Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
57823 ENSG00000026751 SLAMF7 Q9NQ25
27074 ENSG00000078081 LAMP3 Q9UQV4
3902 ENSG00000089692 LAG3 P18627
56253 ENSG00000109943 CRTAM O95727
941 ENSG00000121594 CD80 P33681
27299 ENSG00000134028 ADAMDEC1 O15204
91543 ENSG00000134321 RSAD2 Q8WXG1
7739 ENSG00000147394 ZNF185 O15231
4599 ENSG00000157601 MX1 P20591

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
ABATACEPTCD80ProteinINHIBITORT-lymphocyte activation antigen CD80 inhibitor40
TEBOTELIMABLAG3AntibodyINHIBITORProgrammed cell death protein 1 inhibitor20
IERAMILIMABLAG3AntibodyINHIBITORLymphocyte activation gene 3 protein inhibitor20
FIANLIMABLAG3AntibodyINHIBITORLymphocyte activation gene 3 protein inhibitor20
BELATACEPTCD80ProteinINHIBITORT-lymphocyte activation antigen CD80 inhibitor40
GALIXIMABCD80AntibodyINHIBITORT-lymphocyte activation antigen CD80 inhibitor30
MK-4280LAG3UnknownINHIBITORLymphocyte activation gene 3 protein inhibitor20
ELOTUZUMABSLAMF7AntibodyINHIBITORSLAM family member 7 inhibitor40
AZINTUXIZUMAB VEDOTINTUBB1AntibodyINHIBITORTubulin inhibitor10
RELATLIMABLAG3AntibodyINHIBITORLymphocyte activation gene 3 protein inhibitor21

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-859

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-06100FGFR3down-regulatesSOX11repressesR-859193Drugs (10)
CMF-10366FGGup-regulatesSOX11repressesR-859193Drugs (10)
CMF-12151TMEM132Dup-regulatesSOX11repressesR-859193Drugs (10)
CMF-13933HRH2down-regulatesSOX11repressesR-859195Drugs (10)